Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

InvaGen to acquire Avenue Therapeutics for $215m

pharmaceutical-technologyNovember 14, 2018

Tag: share , InvaGen , Avenue Therapeutics , share

PharmaSources Customer Service